Stockreport

Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update

Merrimack Pharmaceuticals, Inc.  (MACK) 
Last merrimack pharmaceuticals, inc. earnings: 3/6 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.merrimack.com/investor-relations
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced receipt of $2.25 million in connec [Read more]